HALOZYME THERAPEUTICS - INCYTE GRANTED RIGHTS TO DEVELOP ENHANZE WITH MUTCALR PROGRAM AND OPTION FOR TWO ADDITIONAL TARGETS

Reuters · 1d ago

Please log in to view news